Innovations within Precision Oncology: Evolution of a Biomarker - a Case Study of KRAS-G12C

Quest Diagnostics Oncology Associate Medical Director Mark Kruzel, MD, MBA recently discussed the evolving biomarker landscape for non-small cell lung cancer (NSCLC) during the University of Miami Pathology Conference 2022.

 

Dr. Kruzel’s presentation, available on video, raises awareness of KRAS G12C as an actionable biomarker for NSCLC, and reviews available methods and clinical guidance recommendations for biomarker testing at the diagnosis of NSCLC. 

Date:
May 12, 2022
Location:
This webinar was first presented live (virtual) at the University of Miami Pathology Conference 2022, and was later posted as an on-demand webinar.
Presenter(s):
Mark Kruzel

Related content

On-Demand Webinar
Precision Medicine: Your Role in Advancing the Future of Cancer Care
On-Demand Webinar
Hemepath Master Class Myeloid Neoplasms MPN MDS AML
On-Demand Webinar
Current state of Pharmacogenomics and its future
Audio Podcast
Exploring Digital Pathology and Artificial Intelligence
Audio Podcast
Optimize Oncology Care with Clinical Pathways
Publication
Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
On-Demand Webinar
KRAS G12C Mutation: An Emerging Biomarker for NSCLC
On-Demand Webinar
Hereditary Cancer Care Starts in Primary Care